However, prevalence was found to plateau over time, suggesting neuropathic pain may be isolated or intermittent events in some patients with type 1 diabetes. “The features and burden of neuropathic ...

MORRISTOWN, N.J.--(BUSINESS WIRE)--Averitas Pharma, Inc., the U.S. subsidiary of Grünenthal, with advisory support from The Foundation for Peripheral Neuropathy (FPN) today revealed the findings from ...

Faecal transplants have been found to treat diabetes-related nerve pain, a complication affecting more than half of people with diabetes that causes tingling, numbness and stinging. Liping Zhao at ...

How can patients and clinicians effectively manage diabetic neuropathic pain in 2024? At the French Diabetes Society congress, three experts provided a comprehensive overview of the treatment for ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...

Diabetic amyotrophy is a rare complication of diabetes that impacts the nerves in the lower body, especially the hip and thigh. It can cause weakness, muscle loss, and debilitating pain, making it ...

Diabetic peripheral neuropathy, otherwise known as nerve pain, caused by diabetes, can have a severe impact on someone’s quality of life. This pain is often associated with tingling, numbness, and ...

THE WOODLANDS, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX) today announced the presentation of clinical data from the company’s Phase 2b PROGRESS ...

Diabetic neuropathy is a common complication of diabetes. It refers to nerve damage due to long periods of high blood sugar levels. In addition to controlling blood sugars, some medications are ...

(RTTNews) - Lexicon Pharmaceuticals Inc. (LXRX) announced that the U.S. FDA raised no objections to advancing Pilavapadin into Phase 3 development following a successful End-of-Phase 2 meeting for the ...